FY2026 · ended Jun 30, 2026 · Revenue $12.74M, +5.7% YoY · Filed Oct 13, 2026
Escalon Medical Corp. (ESMC) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $12.7 million and net income of $4.0 million. Free cash flow was -$407,025. As of Jun 30, 2026 it held $3.1 million in cash and investments and $835,865 in total debt.
Revenue
$12.74M
+5.7% vs prior year
Net income
$4.01M
+3702.5% vs prior year
Operating cash flow
$-402,604
-205.7% vs prior year
Free cash flow
$-407,025
-208.0% vs prior year
EPS
$0.27
Dividend per share
None
Shares outstanding
7.42M
+0.0% vs prior year
Net cash
$2.23M
FY 2026
Operating margin
0.4%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- ESMC (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- PA
- Headquarters
- Wayne, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 862668
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $12.7M | $12.0M | $12.0M | $12.2M | $10.7M |
| Operating income | $45,235 | $133,217 | -$104,476 | $478,543 | -$470,063 |
| Net income | $4.0M | $105,525 | -$125,261 | $456,826 | $18,081 |
| Diluted EPS | $0.27 | $0.00 | -$0.02 | $0.03 | $0.00 |
| Operating cash flow | -$402,604 | $380,725 | -$602,771 | $325,146 | -$1.0M |
| Free cash flow | -$407,025 | $376,845 | -$643,056 | $318,459 | -$1.0M |
| Total assets | $9.1M | $5.0M | $4.8M | $5.3M | $5.2M |
| Total liabilities | $3.2M | $3.1M | $2.9M | $3.4M | $3.7M |
| Stockholders' equity | $5.9M | $1.9M | $1.8M | $1.9M | $1.5M |
| Cash and investments | $3.1M | $545,835 | $209,033 | $889,674 | $593,869 |
| Total debt | $835,865 | $254,536 | $216,037 | $543,741 | $1.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Oct 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Jan 29, 2026 | Jan 23, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-K | Annual report | Sep 29, 2025 | Jun 30, 2025 |
All 465 Escalon Medical Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.